US Aid Cuts Devastate African HIV Programs, Threatening Decades of Progress

In January 2025, health workers across East Africa, including pediatrician Dr. Theopista Masenge in Tanzania, faced an abrupt 'stop work' order on critical HIV programs aimed at preventing mother-to-child transmission, a stark contradiction to the Trump administration stated priority of eradicating the disease. These sudden cuts, part of a wider freeze on US foreign aid, immediately crippled efforts, leading to a dramatic drop in new patient enrollments and vital viral load testing across the region. This devastating policy shift stems from the Trump administration 'America First Global Health Strategy' and the controversial dismantling of the United States Agency for International Development (USAID), which funneled billions into global health initiatives like PEPFAR for decades. Reports from July and August 2026 show that these agreements slash health funding to 18 countries by nearly 60% of pre-2025 levels by 2030, underspending billions appropriated by Congress. The cuts have created a severe bottleneck for new HIV patients, especially men and young people, and fostered widespread fear of antiretroviral drug shortages, undermining years of progress against the epidemic. As of September 2026, disruptions to HIV/AIDS services for vulnerable populations, including pregnant women and children, persist across Tanzania and other affected nations, despite some limited US government funding reportedly returning. The new bilateral health agreements raise concerns about leveraging aid for US interests, and the US notably voted against a recent UN Political Declaration on HIV/AIDS, signaling a continued distancing from multilateral efforts. With PEPFAR support set to phase out in some key countries like South Africa by early 2027, the future of global HIV response remains uncertain, placing millions at risk.